Published in BMJ on November 16, 1988
Hormone replacement therapy and the cardiovascular system. Nonlipid effects. Drugs (1994) 1.61
The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy. Br J Gen Pract (1991) 1.27
Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25
Lifelong exercise and stroke. BMJ (1993) 1.22
Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging (2008) 1.20
Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest (1992) 1.13
Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage. BMC Neurosci (2010) 1.06
Overweight and stroke in the Whitehall study. J Epidemiol Community Health (1991) 1.03
Drugs in cerebral and peripheral arterial disease. BMJ (1990) 0.98
Oestradiol-induced relaxation of rabbit basilar artery by inhibition of voltage-dependent Ca channels through GTP-binding protein. Br J Pharmacol (1996) 0.93
The effect of ovariectomy and estrogen on penetrating brain arterioles and blood-brain barrier permeability. Microcirculation (2009) 0.87
Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci (2002) 0.86
Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology (2008) 0.84
17β-estradiol increases expression of the oxidative stress response and DNA repair protein apurinic endonuclease (Ape1) in the cerebral cortex of female mice following hypoxia. J Steroid Biochem Mol Biol (2013) 0.79
That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention. Ann Rheum Dis (1993) 0.78
The menopause and hormone replacement therapy. Postgrad Med J (1992) 0.77
Functional and structural brain changes associated with methamphetamine abuse. Brain Sci (2012) 0.77
Estrogen deficiency and low-calcium diet increased bone loss and urinary calcium excretion but did not alter arterial stiffness in young female rats. J Bone Miner Metab (2008) 0.77
Impact of methodology on estrogens' effects on cerebral ischemia in rats: an updated meta-analysis. BMC Neurosci (2014) 0.77
Chronic black tea extract consumption improves endothelial function in ovariectomized rats. Eur J Nutr (2015) 0.75
Hormone replacement therapy. J R Soc Med (1991) 0.75
Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits. Br J Gen Pract (1992) 0.75
Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen. Stroke (2016) 0.75
Orchiectomy or testosterone receptor blockade reduces intestinal mucosal damage caused by ischemia-reperfusion insult. Pediatr Surg Int (2007) 0.75
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet (1980) 5.79
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med (1985) 3.21
Sex-hormone-binding globulin. Clin Endocrinol (Oxf) (1974) 3.11
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62
Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol (1978) 2.07
Noncontraceptive estrogens and myocardial infarction in young women. JAMA (1980) 1.88
An evaluation of risk factors for stroke in a Dutch community. Stroke (1982) 1.79
Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet (1981) 1.77
Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. Am Heart J (1986) 1.71
Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke (1982) 1.67
Risk of stroke in male cigarette smokers. N Engl J Med (1986) 1.60
Exercise in the prevention of coronary heart disease. Prev Med (1984) 1.55
Work activity of longshoremen as related to death from coronary heart disease and stroke. N Engl J Med (1970) 1.49
Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol (1979) 1.39
Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA (1983) 1.29
Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet (1987) 1.29
Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke (1985) 1.28
Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med (1983) 1.28
Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland. Stroke (1982) 1.22
Postmenopausal estrogen use and heart disease. N Engl J Med (1986) 1.19
Exercise in coronary heart disease. Sports Med (1986) 1.18
Cardiovascular disease and hormone replacement treatment: a pilot case-control study. Br Med J (Clin Res Ed) (1981) 1.15
Factors related to stroke incidence in Hawaii Japanese men. The Honolulu Heart Study. Stroke (1980) 1.14
Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med (1976) 1.13
The effects of long-term estrogen on hysterectomized women. Am J Obstet Gynecol (1974) 1.05
Cerebrovascular disease in the biracial population of Evans County, Georgia. Arch Intern Med (1971) 1.03
Coronary risk and estrogen use in postmenopausal women. Am J Epidemiol (1978) 1.02
Noncontraceptive estrogens and nonfatal myocardial infarction. JAMA (1978) 0.96
Use of postmenopausal hormones and risk of myocardial infarction. Circulation (1981) 0.96
Hypertension and cardiac impairments increase stroke risk. Geriatrics (1978) 0.95
Estrogen use and stroke risk in postmenopausal women. Am J Epidemiol (1976) 0.94
Regulation of prostacyclin and thromboxane production by human umbilical vessels: the effect of estradiol and progesterone in a superfusion model. Prostaglandins Leukot Med (1982) 0.91
Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke (1985) 0.89
Characteristics of longshoremen related fatal coronary heart disease and stroke. Am J Public Health (1971) 0.88
Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids. Acta Endocrinol (Copenh) (1977) 0.88
A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol (1979) 0.88
Physical activity levels and coronary heart disease. Analysis of epidemiologic and supporting studies. Med Clin North Am (1985) 0.86
Chronic disease in former college students v. Early precursors of fatal stroke. Am J Public Health Nations Health (1967) 0.86
Differential clinical response to oestrogens after menopause. Med J Aust (1982) 0.84
Estrogen use and myocardial infarction risk: a case-control study. Prev Med (1984) 0.81
Alcohol and strokes. N Engl J Med (1982) 0.78
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Endogenous hormones and breast cancer risk. Epidemiol Rev (1993) 3.27
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst (2001) 3.05
Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst (1994) 2.93
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
Aspirin use and chronic diseases: a cohort study of the elderly. BMJ (1989) 2.89
Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med (1995) 2.83
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (1997) 2.74
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
Toward the primary prevention of cancer. Science (1991) 2.41
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer (1992) 2.40
Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 2.36
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ (1970) 2.34
Decreased mortality in users of estrogen replacement therapy. Arch Intern Med (1991) 2.26
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Occupational differences in rates of lung cancer. J Occup Med (1976) 2.19
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Estrogens and breast cancer. Carcinogenesis (1996) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ (1997) 2.05
The growing importance of California arboviruses in the etiology of human disease. Prog Med Virol (1971) 2.04
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol (2001) 2.02
Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics (1976) 2.00
Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99
Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet (2000) 1.98
Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res (1986) 1.98
Yellow fever immunity surveys in northern Uganda and Kenya and eastern Somalia, 1966-67. Bull World Health Organ (1968) 1.96
Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology (1991) 1.96
Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst (1986) 1.95
Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer (1987) 1.91
Aromatase and breast cancer susceptibility. Endocr Relat Cancer (1999) 1.89
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85
The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res (1995) 1.84
Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet (1981) 1.77
N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res (1982) 1.70
The epidemiology of endometrial cancer in young women. Br J Cancer (1983) 1.70
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev (2000) 1.69
Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst (2001) 1.69
Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res (1988) 1.68
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst (1986) 1.66
Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev (1997) 1.64
Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res (1982) 1.64
Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst (1985) 1.63
Lassa fever. Virological and serological studies. Trans R Soc Trop Med Hyg (1972) 1.60
Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst (1985) 1.60
Cancer of the gastrointestinal tract among Japanese and white immigrants in Los Angeles County. J Natl Cancer Inst (1987) 1.59